By Sheeba M. | April 16, 2026
Q1 2026 Cannabis Earnings Preview: What to Expect from Top MSOs
The cannabis industry’s Q1 2026 earnings season kicks off in earnest over the next three weeks, and investors should reset expectations accordingly. After a volatile 2025 that saw several major MSOs miss consensus targets and watch their stock prices punished accordingly, the sector enters this reporting season with lower bar but higher stakes. Revenue growth alone won’t cut it anymore — margins, cash flow, and market share in key states are what matter.
What the Numbers Look Like
Based on available data from state regulatory agencies and preliminary operator guidance, aggregate Q1 revenue for the top 10 U.S. MSOs should come in around $2.8–3.1 billion — up roughly 4–6% sequentially from Q4 2025. That’s respectable growth, but the devil is in the details. Several operators have guided to lower than expected gross margins, citing pricing pressure in mature recreational markets and promotional intensity in states like Colorado and Oregon.
Green Thumb Industries is expected to post revenue around $280–300 million for the quarter, with EBITDA margins potentially landing in the 20–23% range. Curaleaf continues to be the revenue leader but faces the most acute competitive pressure in its home Massachusetts market, where licensing growth has outpaced demand growth. Trulieve remains the Florida story to watch — the state’s medical market has proven more resilient than many expected, but recreational expansion remains in limbo pending legislation.
Florida: The Make or Break State
Florida represents the most important state-level story for Q1 earnings. The market has transitioned from pure medical to a hybrid medical-recreational framework following the 2024 adult-use ballot initiative, and operators are still calibrating their product mixes and pricing accordingly. Cansortium and Verano both have substantial Florida exposure, and their results will signal whether the recreational buildout is on track.
Store count growth in Florida has been aggressive — the state added over 200 new dispensary locations in the past 12 months. That’s good for consumers but challenging for per-store revenue metrics. Investors should focus on same-store sales trends rather than headline top-line figures.
California: Still a Problem
Nobody wants to talk about California openly, but the numbers are what they are. The world’s largest cannabis market remains effectively broken at the operator level. Tax structures that layer a 15% excise tax, a cultivation tax, and local taxes on top of standard business overhead have pushed many operators to operate at break-even or below. Cresco Labs has been one of the more vocal advocates for tax reform, and their Q1 commentary will be worth watching for signals on whether the Newsom administration’s proposed tax adjustments gain any traction.
The expectation is that California results remain ugly through at least mid-2026, with meaningful recovery not arriving until 2027 at the earliest. That’s already priced into most MSO valuations, but the actual reported numbers still carry sentiment weight.
Cash Flow: The Real Story
Beyond revenue, watch for cash burn rates and balance sheet health. Several operators entered 2026 with elevated debt loads and limited runway. Innovative Industrial Properties continues to be a bellwether for the industry’s real estate health — their tenant rent coverage ratios and any signs of covenant stress will ripple through the sector.
Look for operators who are demonstrating genuine free cash flow generation or clear paths to it. Companies that can self-fund expansion without constant equity raises are trading at a premium, and that premium should hold or expand through this earnings season.
What to Watch in Earnings Calls
- Management commentary on Q2 guidance — forward visibility matters
- Any updates on federal rescheduling or banking reform impacts on operations
- Florida recreational legislation timeline and store expansion pace
- California tax reform status and operator profitability roadmap
- International expansion optionality — Canadian LPs eyeing US market entry
Sources
- Leafly Annual Report — State-by-state market sizing and growth projections
- Bloomberg Cannabis Index — Sector performance benchmarks and analyst estimates
- Florida Office of Justice — State cannabis program enrollment and sales data
Track quarterly cannabis stock performance with the Weedstock Real-Time Stock Tracker